Andrew Bellinger, Sek Kathiresan, and C. Michael Gibson talk about the phase 1b trial of what investigators hope may be a one-time genetic fix for hyperlipidemia.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
